Strand Therapeutics, the programmable mRNA company developing curative therapies for cancer and other diseases, has appointed Colleen Wilson as chief people officer.

She comes with more than 23 years of leadership and operational experience in human resources.

She most recently served Rheos Medicines as SVP, human resources and has also consulted for multiple public and private biotechnology companies at various stages of development.

Prior to founding her own consulting firm, she was VP and head of human resources at Chiasma, Inc. and also led the human resources function at Omni-Guide Surgical and Rib-X Pharmaceuticals. Wilson has also held HR roles at Infinity Pharmaceuticals, Genzyme Corporation, Targanta Therapeutics and Therion Biologics.

“Colleen brings broad and extensive capabilities as an operational leader in developing strategies that attract top talent and establishing organizational culture practices for continued growth. I look forward to her contributions as we ensure Strand remains a destination for top talent, and a diverse, inclusive and collaborative environment for our employees,” said Jake Becraft, Ph.D., CEO & Co-Founder, Strand Therapeutics.

"I look forward to working with the entire Strand team, as the company advances its pipeline to bring the promise of mRNA-based therapeutics beyond vaccines to treat significant unmet medical needs such as cancer,” said Wilson.

She earned her MBA from Babson College and a bachelor’s degree from the University of New Hampshire.